Dr.Datsons Labs (Delisted) share news and announcements
BSE: 533412
Formerly Aanjaneya Lifecare
Last traded ₹6.40 on 21 May 2015
Delisted on 14 Feb 2020.
Dr.Datsons Labs share news and announcements
899 announcements, routine notices left out, newest first. Page 3 of 18.
Oct 2014
31 Oct · Board meeting
(1) To take on record the Unaudited (Provisional) Financial Results for the Second quarter ended September 30, 2014. (2) Any other matter with the permission of the Chair.21 Oct · Board meeting
Dr.Datsons Labs Ltd has informed BSE that the Company has closed its FCCB Issue on October 21, 2014. The said issue was opened for subscription on October 17, 2014. As decided in ....17 Oct · Board meeting
Dr.Datsons Labs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 17, 2014, have decided that the date of opening of issuance of FCCB up to ....16 Oct · Board Meeting on Oct 17, 2014
Dr.Datsons Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 17, 2014, inter alia, to announce the date of opening of issuance of ....14 Oct · Shareholding Pattern For September 30, 2014
Sep 2014
19 Sep · Meeting
Dr.Datsons Labs Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2014 to September 30, 2014 (both days inclusive) ....
Aug 2014
25 Aug · Management
Dr.Datsons Labs Ltd has informed BSE about appointment of Mr. Rajendra Kamath, Non Executive Chairman of the Company, with effect from August 21, 2014.25 Aug · Management
Dr. Datson's Labs Limited has informed the Exchange regarding appointment of Mr. Rajendra Kamath, Non Executive Chairman of the Company, with effect from August 21, 2014.14 Aug · Board meeting
Dr.Datsons Labs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 14, 2014, inter alia, has decided the following: - Authorize Dr. Kannan ....14 Aug · Meeting
Dr. Datson's Labs Limited has informed the Exchange that the Company has fixed Book Closure from September 24, 2014 to September 30, 2014 (both days inclusive) for the purpose of Annual General Meeting of the Company scheduled to be held on September 30, 2014.14 Aug · Board meeting
Dr. Datson's Labs Limited has informed the Exchange that the Board of Directors of the Company held on August 14, 2014, decided: 1) Adopted and Approved the Notice & Directors Report along with the Corporate Governance Report of the Company for the financial year 2013-14; 2) Authorize Dr. Kannan Vishwanath, Vice Chairman & Managing Director and/or Mr. Yogesh Patel, Company Secretary of the Company, to oversee the entire E-voting Process at the AGM of the Company; 3) Appointed Mr. Deep Shukla, Practicing Company Secretary as a Scrutinizer to conduct the entire voting Process at the AGM of the Company [including e-voting] and to submit the Report to the Board of Directors for declaration of the results thereof. Further, we wish to inform the BSE & NSE that in terms of Section 108 of the Companies Act, 2013 and Rule 20(1) of the Companies (Management & Administration) Rules 2014, the Company will provide its Shareholders the facility to exercise their vote for transacting the items of ordinary and special business at the ensuing 8th Annual General Meeting (AGM) to be held on September 30, 2014, by electronic means. The Company would be availing e-voting services of Central Depository Services (India) Limited (CDSL), Further pursuant to Rule 20(3)(vii) of the Companies (Management & Administration) Rules 2014, the Company has fixed August 29, 2014 as the cutoff date to determine the Shareholders (holding equity shares of the Company in both electronic and/or physical form) eligible to cast their vote for transacting the items of ordinary and special business at the ensuing 8th AGM.1 Aug · Board Meeting on August 14, 2014
Dr.Datsons Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 14, 2014, inter alia, to transact the following: 1. To take on ....1 Aug · Board meeting
To take on record the Unaudited (Provisional) Financial Results for the first quarter ended June 30, 2014. To adopt and approve the Notice & Directors Report of the Company along with the Corporate Governance Report for financial year 2013-14. To finalize the dates of Book Closure for the purpose of forthcoming 08th Annual General Meeting. To finalize the date, venue and time for convening 08th Annual General Meeting of the Members of the Company. To consider appointment of Scrutinizer to oversee the e-voting process at AGM of the Company. Any other matter with the permission of the Chair. Further, we wish to inform you that as per the Company's Code of Conduct for Prohibition of Insider Trading, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992, the trading window for dealing in the securities of the Company will be closed for the purpose of declaration of financial results of the Company for the quarter ended June 30, 2014 from August 1, 2014 to August 15, 2014. Accordingly, all the Designated Employees (including Directors) of the Company have been intimated not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of trading window.
Jul 2014
21 Jul · Change in address of Corporate/ Admin Office
Dr.Datsons Labs Ltd has informed BSE that the Change in Corporate/ Admin Office of the Company: From Plot No 34, Postal Colony, Chembur, Mumbai 400 071 India To Dr. ....17 Jul · Update on FCCBs
Dr.Datsons Labs Ltd has informed BSE that the Company has successfully completed its obligations towards the FCCB Bond Holders for 40 Million USD. There is no Unpaid Debt by the Company ....16 Jul · Shareholding Pattern For June 30, 2014